Back
Pan American Silver Corp. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
83
PAAS.TO
Pan American Silver Corp.
Last Price:
$60.37
Seasonality Move:
8.6%
Buy
90
KYMR
Kymera Therapeutics, Inc.
Last Price:
$94.38
Seasonality Move:
7.7%
Buy
83
Pan American Silver Corp. (PAAS.TO)
is a Buy
Is Pan American Silver Corp. a Buy, Sell or Hold?
-
The current Pan American Silver Corp. [PAAS.TO] share price is $60.37. The Score for PAAS.TO is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
-
PAAS.TO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
90
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
PAAS.TO Stock Price Chart
What is Pan American Silver Corp.'s stock price today?
-
The Pan American Silver Corp. share price today is $60.37The current trend is moderately bullish and PAAS.TO is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $94.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
PAAS.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.74 | Buy |
| Relative Strength Index (14 RSI): | 59.9 | Buy |
| Chaikin Money Flow: | -513027 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.35 - 60.73) | Buy |
| Bollinger Bands (100): | (43.2 - 56.04) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 86.88 | Buy |
| Chaikin Money Flow: | -462379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.8 - 71.72) | Buy |
| Bollinger Bands (100): | (43.38 - 63.26) | Buy |
PAAS.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.91 | Sell |
| 20-day SMA: | 57.25 | Buy |
| 50-day SMA: | 54.24 | Buy |
| 200-day SMA: | 43.02 | Buy |
| 8-day EMA: | 60.72 | Sell |
| 20-day EMA: | 57.98 | Buy |
| 50-day EMA: | 54.35 | Buy |
| 200-day EMA: | 44.93 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70 | Buy |
| 20-day SMA: | 66.61 | Buy |
| 50-day SMA: | 61.97 | Buy |
| 200-day SMA: | 44.25 | Buy |
| 8-day EMA: | 72.36 | Buy |
| 20-day EMA: | 67.57 | Buy |
| 50-day EMA: | 61.93 | Buy |
| 200-day EMA: | 49.42 | Buy |
Pan American Silver Corp. Earnings Growth & PAAS.TO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.83 per share, and an increase next year of $1.81 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.
Pan American Silver Corp. Technical Analysis
| Nov 25 | Nov 26 | Nov 27 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 27 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||